Molecular profiling of patient-derived breast cancer xenografts
暂无分享,去创建一个
Anne Vincent-Salomon | Olivier Delattre | David Gentien | Fabien Reyal | Elisabetta Marangoni | Pierre Gestraud | Sergio Roman-Roman | P. Gestraud | A. Vincent-Salomon | O. Delattre | S. Roman-Roman | C. Lucchesi | F. Reyal | M. Poupon | P. de Cremoux | P. Cottu | E. Marangoni | D. Gentien | F. Assayag | J. Fontaine | D. Decaudin | C. Decraene | N. Auger | Charlotte Guyader | Charles Decraene | Carlo Lucchesi | Nathalie Auger | Franck Assayag | Ludmilla De Plater | Marie-France Poupon | Paul Cottu | Patricia De Cremoux | Jean-Jacques Fontaine | Didier Decaudin | C. Guyader | L. de Plater | P. de Crémoux
[1] E. Sausville,et al. Contributions of human tumor xenografts to anticancer drug development. , 2006, Cancer research.
[2] H. Höfler,et al. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. , 1999, Cancer genetics and cytogenetics.
[3] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[4] Jian Li,et al. Estimation of tumor heterogeneity using CGH array data , 2009, BMC Bioinformatics.
[5] B. Dutrillaux,et al. Hormone escape is associated with genomic instability in a human prostate cancer model , 2009, International journal of cancer.
[6] Alessandro De Luca,et al. Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy. , 2008, Gynecologic oncology.
[7] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[8] Nicolas Stransky,et al. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. , 2008, Cancer research.
[9] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[10] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[11] H. Fiebig,et al. Human Tumor Xenografts and Explants , 2002 .
[12] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[13] A. Vincent-Salomon,et al. A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays , 2007, Clinical Cancer Research.
[14] A. Vincent-Salomon,et al. Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS * Study , 2003, Histopathology.
[15] F. Pépin,et al. Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.
[16] Céline Rouveirol,et al. VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profiles , 2006, Bioinform..
[17] A. Maier,et al. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. , 2004, European journal of cancer.
[18] A. Ashworth,et al. Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation , 2010, British Journal of Cancer.
[19] K. Garber. From human to mouse and back: 'tumorgraft' models surge in popularity. , 2009, Journal of the National Cancer Institute.
[20] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] Farin Kamangar,et al. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[23] T. Sørlie,et al. Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models , 2009, Molecular oncology.
[24] J. Thiery,et al. Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast , 2008, Clinical Cancer Research.
[25] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[26] O. Myklebost,et al. Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations , 2012, Cancer.